ARK Investment Management LLC
Source: SEC Form 13F · as of Mar 2026ARK Investment Management LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $753.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$753.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Beam Therapeutics Inc. (BEAM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BEAMBeam Therapeutics Inc. | 12,133,433 | $289.1M |
| NTLAIntellia Therapeutics, Inc. | 14,509,247 | $186.0M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 40,212,769 | $123.5M |
| ABSIAbsci Corporation | 13,726,169 | $41.2M |
| ADPTAdaptive Biotechnologies Corp | 2,092,969 | $29.1M |
| NRIXNurix Therapeutics, Inc. | 1,721,135 | $26.7M |
| IONSIONIS PHARMACEUTICALS INC | 288,716 | $21.7M |
| CMPSCOMPASS Pathways plc | 3,301,050 | $18.3M |
| CNTNCanton Strategic Holdings, Inc. | 3,695,084 | $12.1M |
| MDWDMediWound Ltd. | 129,961 | $2.1M |
| DRTSAlpha Tau Medical Ltd. | 292,134 | $2.1M |
| TEVATeva Pharmaceutical Industries Limited | 68,279 | $2.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.